A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (3) , 505-516
- https://doi.org/10.1016/s0149-2918(98)80060-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.The Journal of Clinical Psychiatry, 1997
- Time to Recovery, Chronicity, and Levels of Psychopathology in Major DepressionArchives of General Psychiatry, 1992
- Psychoactive Drugs and Human Sexual Behavior: The Role of Serotonergic ActivityJournal of Psychoactive Drugs, 1992
- How often is medication taken as prescribed? A novel assessment techniqueJAMA, 1989
- One-Month Prevalence of Mental Disorders in the United StatesArchives of General Psychiatry, 1988
- A double-blind study of bupropion and placebo in depressionAmerican Journal of Psychiatry, 1984
- Strategies for enhancing patient complianceJournal of Community Health, 1980
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960